Scarica l'app Stockscreener
6.395
7.12%
0.425
Precedente Chiudi:
$5.97
Aprire:
$5.97
Volume 24 ore:
120.19K
Relative Volume:
0.72
Capitalizzazione di mercato:
$66.09M
Reddito:
$442.00K
Utile/perdita netta:
$-30.46M
Rapporto P/E:
-1.4339
EPS:
-4.46
Flusso di cassa netto:
$-27.47M
1 W Prestazione:
+10.83%
1M Prestazione:
+2.65%
6M Prestazione:
+66.97%
1 anno Prestazione:
+21.12%
Intervallo 1D:
$5.90
$6.655
Intervallo di 1 settimana:
$5.71
$6.655
Portata 52W:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Nome
Clene Inc
Settore
Industria
Telefono
801-676-9695
Indirizzo
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Confronta CLNN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.395 | 61.69M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-02 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-28 | Iniziato | Oppenheimer | Outperform |
Clene Inc Borsa (CLNN) Ultime notizie
Is Clene Inc. (84C0) stock a defensive play amid uncertainty2025 Volume Leaders & AI Powered Market Trend Analysis - ulpravda.ru
Chart Watch: Will Aterian Inc stock see PE expansionWatch List & Short-Term Trading Alerts - moha.gov.vn
Clene (CLNN) Secures $28 Million Through Direct Offering - GuruFocus
D. Boral Capital Maintains 'Buy' Rating for CLNN with $23 Target - GuruFocus
Clene secures $28 million in registered direct offering for ALS drug - Investing.com India
Clene announces registered direct offering of over $28 million - MarketScreener
Clene Inc. Announces Oversubscribed Registered Direct Offering Exceeding $28 Million to Fund ALS Treatment Development - Quiver Quantitative
Clene Announces Registered Direct Offering of Over $28 Million - MarketScreener
Can Clene Inc. Equity Warrant stock weather global recessionEarnings Recap Report & Growth-Oriented Investment Plans - ulpravda.ru
Will Clene Inc. Equity Warrant stock reach Wall Street targetsJobs Report & Free Long-Term Investment Growth Plans - ulpravda.ru
Chipmakers Recap: Is Clene Inc. (84C0) stock a top hedge fund pickMarket Weekly Review & Long Hold Capital Preservation Plans - ulpravda.ru
How Clene Inc. Equity Warrant stock reacts to Fed rate cutsJuly 2025 Drop Watch & Daily Price Action Insights - ulpravda.ru
Why Clene Inc. Equity Warrant stock remains on buy listsEarnings Trend Report & Fast Exit and Entry Strategy Plans - ulpravda.ru
Will Clene Inc. stock gain from strong economyStop Loss & AI Based Buy/Sell Signal Reports - ulpravda.ru
Is Clene Inc. Equity Warrant stock a buy before product launchesJuly 2025 Highlights & Low Risk Profit Maximizing Plans - ulpravda.ru
Top Nanotechnology Stocks To Follow TodayJanuary 8th - MarketBeat
Why Clene Inc. (84C0) stock stays undervalued2025 Buyback Activity & Reliable Entry Point Trade Alerts - ulpravda.ru
How Clene Inc. stock reacts to Fed rate cutsPortfolio Gains Report & Risk Controlled Swing Alerts - ulpravda.ru
Published on: 2026-01-08 21:03:18 - ulpravda.ru
Clene Inc. ten percent owner Ugwumba sells $78k in shares By Investing.com - Investing.com India
Clene Inc. ten percent owner Ugwumba sells $78k in shares - Investing.com India
Market Outlook: Will Clene Inc Equity Warrant stock continue dividend increasesJuly 2025 PostEarnings & Entry Point Strategy Guides - moha.gov.vn
Clene to Present at the Emerging Growth Conference - Investing News Network
Best Nanotechnology Stocks To Follow TodayJanuary 5th - MarketBeat
Top Nanotechnology Stocks To Add to Your WatchlistJanuary 4th - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 13,095 Shares of Stock - MarketBeat
Chidozie Ugwumba Sells 4,015 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Published on: 2026-01-01 16:53:08 - moha.gov.vn
Nanotechnology Stocks To Follow TodayDecember 29th - MarketBeat
Nanotechnology Stocks To ResearchDecember 31st - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 8,096 Shares - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,138 Shares - MarketBeat
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123 By Investing.com - Investing.com Nigeria
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123 - Investing.com
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 6,831 Shares of Stock - MarketBeat
Clene Inc: Ugwumba sells $73k in CLNN stock By Investing.com - Investing.com South Africa
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 3,350 Shares - MarketBeat
Clene Inc: Ugwumba sells $73k in CLNN stock - Investing.com
Promising Nanotechnology Stocks To Follow TodayDecember 19th - MarketBeat
Short Interest in Clene Inc. (NASDAQ:CLNN) Increases By 47.4% - MarketBeat
Clene Inc. (NASDAQ:CLNN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Promising Nanotechnology Stocks To Follow NowDecember 22nd - MarketBeat
Promising Nanotechnology Stocks To Keep An Eye OnDecember 25th - MarketBeat
Nanotechnology Stocks To Keep An Eye OnDecember 23rd - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,367 Shares of Stock - MarketBeat
Chidozie Ugwumba Sells 5,582 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Promising Nanotechnology Stocks To ResearchDecember 8th - MarketBeat
Have Insiders Sold Clene Shares Recently? - simplywall.st
Clene Inc Azioni (CLNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):